Related Experiment Video

Updated: Apr 27, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

552

Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs

Abhineet Uppal1, Mark K Ferguson, Mitchell C Posner

  • 1Department of Surgery, The University of Chicago, MC 5029, 5841 S. Maryland Ave, Chicago, IL, 60637, USA, abhineet.uppal@uchospitals.edu.

Clinical & Experimental Metastasis
|June 28, 2014
PubMed

Insights

Micro-RNAs regulate cancer metastasis, differentiating limited oligometastasis from widespread polymetastasis. Understanding these micro-RNAs may lead to targeted therapies for controlling cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Oligometastasis is a cancer state with limited tumors, potentially treatable with locoregional therapy.
  • Current understanding of progression from primary tumors to oligometastasis versus polymetastasis lacks detail.
  • Micro-RNAs are implicated in cancer progression and metastasis.

Purpose of the Study:

  • To review the role of micro-RNAs in regulating metastasis.
  • To explore how micro-RNAs differentiate oligometastatic from polymetastatic progression.
  • To highlight micro-RNAs as potential therapeutic targets for controlling cancer spread.

Main Methods:

  • Review of existing literature on micro-RNAs and cancer metastasis.
  • Analysis of metastatic samples from oligometastatic and polymetastatic patients.
  • Examination of the functions of specific micro-RNAs in the metastatic cascade.

Main Results:

  • Oligometastasis appears to be a distinct biological entity partly regulated by micro-RNAs.
  • Specific micro-RNAs are associated with oligometastatic disease.
  • These micro-RNAs influence key steps in the metastatic cascade, including epithelial-mesenchymal transition and distant organ proliferation.

Conclusions:

  • Micro-RNAs play a crucial role in the development and progression of cancer metastasis.
  • Micro-RNA profiles may distinguish oligometastatic from polymetastatic disease.
  • Targeting micro-RNAs and their associated genes offers a promising strategy for novel cancer therapies.

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
MicroRNAs01:22

MicroRNAs

9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K